Universe Pharmaceutical Class AUPC
13F holders, Q1 2024 (March 31)2holders
$1.72avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Universe Pharmaceutical Class A (UPC) in their 13F filings. The largest holders were UBS Group AG ($2K) and Acadian Asset Management LLC ($0).
- Company
- Universe Pharmaceutical Class A
- CUSIP
- G9442G112
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
Ownership 2 holders
| UBS Group AG | 0.00% | New | 1,089 | $2K |
| Acadian Asset Management LLC | 0.00% | Reduce -95.4% | 300 | $0 |
"% of holder's portfolio" is UPC's weight in each manager's 13F, not the share of Universe Pharmaceutical Class A the manager owns.